BMS-986094
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-986094, covering 2014-05-09 to 2014-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis C [Phase 2]